Compare Medpace Holdings Inc (MEDP) vs Impinj Inc (PI) Price & Performance

MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.

Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.

Impinj (PI) trades at $178.58, up 1.32% on the day, with a bullish technical outlook supported by moving averages and strong institutional buying interest. The company reported record Q2 2026 revenue and earnings, beating estimates, but maintains negative net income margins. Analyst consensus is strongly bullish with a $186 price target, though high valuation multiples and insider sales present cautionary notes.

Outlook remains positive driven by RFID demand growth and sequential earnings beats, but risks include profitability challenges, high debt-to-asset ratio, and competitive pressures. The stock's current price near consensus target suggests limited upside without further fundamental improvement.